Angiotensin II subtype 2 receptor blockade and deficiency attenuate the development of atherosclerosis in an apolipoprotein E-deficient mouse model of diabetes-Reference-Cited by-同舟云学术

Angiotensin II subtype 2 receptor blockade and deficiency attenuate the development of atherosclerosis in an apolipoprotein E-deficient mouse model of diabetes

Published:2009-12-03 Issue:3 Volume:53 Page:584-592
ISSN:0012-186X
Container-title:Diabetologia
language:en
Short-container-title:Diabetologia

Author:

Koïtka A.,Cao Z.,Koh P.,Watson A. M. D.,Sourris K. C.,Loufrani L.,Soro-Paavonen A.,Walther T.,Woollard K. J.,Jandeleit-Dahm K. A. M.,Cooper M. E.,Allen T. J.

Publisher

Springer Science and Business Media LLC

Subject

Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00125-009-1619-x.pdf

Reference47 articles.

1. Juutilainen A, Lehto S, Ronnemaa T, Pyorala K, Laakso M (2008) Similarity of the impact of type 1 and type 2 diabetes on cardiovascular mortality in middle-aged subjects. Diabetes Care 31:714–719

2. Candido R, Allen TJ, Lassila M et al (2004) Irbesartan but not amlodipine suppresses diabetes-associated atherosclerosis. Circulation 109:1536–1542

3. Brenner BM, Cooper ME, de Zeeuw D et al (2001) Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med 345:861–869

4. Lewis EJ, Hunsicker LG, Bain RP, Rohde RD (1993) The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group. N Engl J Med 329:1456–1462

5. Lewis EJ, Hunsicker LG, Clarke WR et al (2001) Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. N Engl J Med 345:851–860

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cardiometabolic traits mediating the effect of education on the risk of DKD and CKD: a Mendelian randomization study;Frontiers in Nutrition;2024-08-13

2. Pathogenesis of Macrovascular Complications in Diabetes;Textbook of Diabetes;2024-01-12

3. Renin–Angiotensin–Aldosterone System and LOX-1 Interaction in Hypertension with a Focus on Modulation of the Immune System;The Renin Angiotensin System in Cardiovascular Disease;2023

4. Effect of Lactobacillus casei fermented milk on fracture healing in osteoporotic mice;Frontiers in Endocrinology;2022-10-28

5. Construction of an immune-related signature for predicting the ischemic events in patients undergoing carotid endarterectomy;Frontiers in Genetics;2022-10-10